California residents may have seen advertisements regarding the possible link between diabetic drug Actos and bladder cancer. In two separate states, plaintiffs are presenting evidence in cases that could build a foundation for global settlements with the maker of the drug. One case featured closing arguments on Monday, April 7. The other pharmaceutical litigation case resumed court proceedings following a two-week hiatus.
The case that resumed proceedings involves two women, ages 80 and 81. Both women accuse the company of hiding bladder cancer risks from patients and physicians. The women have diabetes and began taken Actos. Both allege that they developed bladder cancer after taking the medication.
The woman filed suit in another state in Dec. 2013. Currently, the plaintiff attorneys are calling expert witnesses to testify about the link between Actos and bladder cancer. They will also try to prove that the company knew about the link and withheld the information.
The second case, which closed on April 7, was the first federal suit against the company. It began on Feb. 3 and is being watched by attorneys and patients across the country.
Mass torts related to possible negligence from a drug maker or any manufacturer require an understanding of the law and a proper approach to the case. Many times, legal experts will wait for the outcome of a single case before moving forward with a class-action case or settlement. Being up to date on legal news within the industry can increase the chance that a claim for compensation is successful, especially when plaintiffs are going up against large medical, pharmaceutical, chemical or technical companies.
Source: Drug Watch, "Billion-Dollar Lawsuit Against Actos Resumes Today" Beau Hooks, Apr. 07, 2014